Inge Pronk

1.2k total citations
15 papers, 965 citations indexed

About

Inge Pronk is a scholar working on Epidemiology, Oncology and Genetics. According to data from OpenAlex, Inge Pronk has authored 15 papers receiving a total of 965 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Oncology and 5 papers in Genetics. Recurrent topics in Inge Pronk's work include Inflammatory Bowel Disease (5 papers), Influenza Virus Research Studies (3 papers) and Viral-associated cancers and disorders (3 papers). Inge Pronk is often cited by papers focused on Inflammatory Bowel Disease (5 papers), Influenza Virus Research Studies (3 papers) and Viral-associated cancers and disorders (3 papers). Inge Pronk collaborates with scholars based in Netherlands, United States and Norway. Inge Pronk's co-authors include Jaap M. Middeldorp, Servi J.C. Stevens, Anje A. te Velde, Floor de Kort, Fiebo J.W. ten Kate, Sander J. H. van Deventer, Martin C. Harmsen, Erik A.M. Verschuuren, Wim van der Bij and T H Thé and has published in prestigious journals such as Blood, The Journal of Immunology and Gastroenterology.

In The Last Decade

Inge Pronk

15 papers receiving 948 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Inge Pronk Netherlands	11	389	366	276	197	184	15	965
E C Ebert United States	21	233 0.6×	263 0.7×	678 2.5×	91 0.5×	130 0.7×	41	1.2k
Matthew J. Lindemann United States	7	146 0.4×	304 0.8×	580 2.1×	355 1.8×	74 0.4×	9	1.1k
Richard S. Blumberg United States	10	153 0.4×	212 0.6×	669 2.4×	126 0.6×	289 1.6×	18	1.3k
Chiedzo Mpofu United Kingdom	6	203 0.5×	255 0.7×	137 0.5×	165 0.8×	418 2.3×	10	988
Don A. Sibley United States	15	92 0.2×	168 0.5×	368 1.3×	79 0.4×	186 1.0×	17	871
William A. Bye Australia	10	150 0.4×	204 0.6×	235 0.9×	87 0.4×	181 1.0×	14	750
J. Navarro Spain	21	116 0.3×	317 0.9×	739 2.7×	258 1.3×	56 0.3×	57	1.3k
Silvia Guglietta United States	15	210 0.5×	237 0.6×	406 1.5×	156 0.8×	72 0.4×	28	1.2k
Christine Bundell Australia	16	168 0.4×	148 0.4×	459 1.7×	56 0.3×	63 0.3×	41	940
Peter Kabel Netherlands	12	130 0.3×	291 0.8×	814 2.9×	299 1.5×	115 0.6×	15	1.3k

Countries citing papers authored by Inge Pronk

Since Specialization

Citations

This map shows the geographic impact of Inge Pronk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge Pronk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge Pronk more than expected).

Fields of papers citing papers by Inge Pronk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inge Pronk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge Pronk. The network helps show where Inge Pronk may publish in the future.

Co-authorship network of co-authors of Inge Pronk

This figure shows the co-authorship network connecting the top 25 collaborators of Inge Pronk. A scholar is included among the top collaborators of Inge Pronk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inge Pronk. Inge Pronk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Berbers, Guy A. M., Marlies A. van Houten, Marjan Kuijer, et al.. (2020). Infant antibody levels following 10-valent pneumococcal-protein D conjugate and DTaP-Hib vaccinations in the first year of life after maternal Tdap vaccination: An open-label, parallel, randomised controlled trial. Vaccine. 38(29). 4632–4639. 10 indexed citations

Pronk, Inge, Marlies A. van Houten, F. G. A. Versteegh, et al.. (2019). Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial. The Lancet Infectious Diseases. 19(4). 392–401. 57 indexed citations

Rijnierse, Anneke, Frank A. Redegeld, Bart R. Blokhuis, et al.. (2010). Ig-Free Light Chains Play a Crucial Role in Murine Mast Cell-Dependent Colitis and Are Associated with Human Inflammatory Bowel Diseases. The Journal of Immunology. 185(1). 653–659. 41 indexed citations

Gijzen, Karlijn, Fredrik Oftung, Sylvie van der Werf, et al.. (2010). Standardization and validation of assays determining cellular immune responses against influenza. Vaccine. 28(19). 3416–3422. 29 indexed citations

Jonges, Marcel, Erhard van der Vries, Ronald Jacobi, et al.. (2010). Influenza Virus Inactivation for Studies of Antigenicity and Phenotypic Neuraminidase Inhibitor Resistance Profiling. Journal of Clinical Microbiology. 48(3). 928–940. 95 indexed citations

Velde, Anje A. te, Inge Pronk, Floor de Kort, & Pieter Stokkers. (2008). Glutathione peroxidase 2 and aquaporin 8 as new markers for colonic inflammation in experimental colitis and inflammatory bowel diseases: an important role for H2O2?. European Journal of Gastroenterology & Hepatology. 20(6). 555–560. 79 indexed citations

Steinbusch, Harry W.M., Inge Pronk, Gert Grauls, et al.. (2007). Inflammatory responses following Chlamydia pneumoniae infection of glial cells. European Journal of Neuroscience. 25(3). 753–760. 10 indexed citations

Velde, Anje A. te, Floor de Kort, Ellen Sterrenburg, et al.. (2006). Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease. Inflammatory Bowel Diseases. 13(3). 325–330. 138 indexed citations

Braat, Henri, Pieter Stokkers, Tijmen J. Hommes, et al.. (2005). Consequence of functional Nod2 and Tlr4 mutations on gene transcription in Crohn’s disease patients. Journal of Molecular Medicine. 83(8). 601–609. 53 indexed citations

10.

Kort, Floor de, Inge Pronk, Anje A. te Velde, et al.. (2005). Functional consequences of NOD2 deficiency in Crohn??s disease patients peripheral blood monocytes derived dendritic cells. European Journal of Gastroenterology & Hepatology. 18(1). A29–A29. 3 indexed citations

11.

Curvers, Wouter L., Luc J. J. Derijks, Pieter Stokkers, et al.. (2003). No predictive value of TPMT genotyping for leukopenia or hepatotoxicity during azathioprine therapy in inflammatory bowel disease. Gastroenterology. 124(4). A49–A49. 8 indexed citations

12.

Montfrans, Catherine van, et al.. (2002). Prevention of colitis by interleukin 10–transduced T lymphocytes in the SCID mice transfer model. Gastroenterology. 123(6). 1865–1876. 60 indexed citations

13.

Verschuuren, Erik A.M., Servi J.C. Stevens, Inge Pronk, et al.. (2001). Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of post-transplant lymphoproliferative disease in lung transplant patients. The Journal of Heart and Lung Transplantation. 20(2). 199–200. 3 indexed citations

14.

Stevens, Servi J.C., Erik A.M. Verschuuren, Inge Pronk, et al.. (2001). Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients. Blood. 97(5). 1165–1171. 254 indexed citations

15.

Stevens, Servi J.C., Inge Pronk, & Jaap M. Middeldorp. (2001). Toward Standardization of Epstein-Barr Virus DNA Load Monitoring: Unfractionated Whole Blood as Preferred Clinical Specimen. Journal of Clinical Microbiology. 39(4). 1211–1216. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact